Biktarvy, formally known as bictegravir, includes a potent single-tablet treatment for managing HIV infection. This formula unites three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the HIV's ability to replicate within the body, remarkably reducing the viral load. For many individuals,